Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Longeveron announced updated Phase 2b ELPIS II trial results for laromestrocel in infants with hypoplastic left heart syndrome (HLHS). While the trial missed its primary efficacy endpoint of RVEF change, additional analysis showed the secondary endpoint of major adverse cardiac events (MACE) achieved statistical significance with only 1 event in the treatment arm versus 8 in the standard of care arm (P=0.043).
Cumberland Pharmaceuticals announced plans to submit a New Drug Application (NDA) for ifetroban to treat cardiomyopathy associated with Duchenne muscular dystrophy (DMD). The submission is supported by Phase 2 FIGHT DMD trial data showing a statistically significant 5.4% improvement in left ventricular ejection fraction (LVEF) compared to a control group. While the FDA expressed concerns regarding the sufficiency of the data package for efficacy requirements, the company is moving forward with the submission following a pre-NDA meeting.
Weave Communications Signs $650M M&A Deal with Francisco Partners
Weave Communications, Inc. completed its acquisition by Francisco Partners in an all-cash transaction valued at approximately $650 million. Under the terms of the deal, Weave stockholders received $7.40 per share, and the company has transitioned to a privately held entity, delisting from the New York Stock Exchange.
Value
$650M
Counterparty
Francisco Partners
“Today marks the start of an exciting new chapter for Weave. For nearly two decades, Weave has built solutions for independent practices caring for patients in communities across the country. Today, more than 40,000 locations rely on us to deepen their relationship with patients through automated communication and engagement solutions. With Francisco Partners’ support and resources, we’re well positioned to deliver even more value to the practices we serve. I want to thank our employees, whose dedication made this milestone possible.”
Brett White, Chief Executive Officer of Weave
“Weave sits at the center of how tens of thousands of healthcare practices communicate with their patients and collect revenue. We are pleased to officially partner with Brett and the Weave team and see significant opportunity to build on that position through continued product innovation in AI-powered patient engagement and payments solutions.”
NewHydrogen, Inc. entered into a securities purchase agreement with SunHydrogen, Inc. to raise approximately $3 million through the issuance of 203,650,000 shares of common stock and warrants to purchase an additional 407,300,000 shares. The common stock was priced at $0.01473 per share, and the proceeds are intended for general corporate purposes and working capital.
North Haven Private Income Fund A M&A Deal with North Haven Private Income Fund LLC
North Haven Private Income Fund A LLC (PIF A) has entered into a definitive merger agreement to be acquired by North Haven Private Income Fund LLC (PIF). The transaction will be a NAV-for-NAV exchange where PIF A unitholders will receive Class I units of PIF, creating a combined entity with approximately $6.6 billion in total investments.
Counterparty
North Haven Private Income Fund LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
PennantPark Private Income Fund Capital Raise of $3.08M
PennantPark Private Income Fund issued and sold 118,703 common shares for aggregate proceeds of approximately $3.08 million on October 1, 2026. The sale was conducted as part of the company's ongoing continuous private offering to accredited investors. Additionally, the company reported a net asset value (NAV) per share of $25.95 as of September 30, 2026.
Applied Materials Partnership with BE Semiconductor Industries N.V.
Applied Materials entered into an accelerated share purchase agreement to increase its minority stake in BE Semiconductor Industries (Besi) to approximately 20%. The investment reinforces a long-term strategic partnership focused on co-innovating advanced packaging and hybrid bonding technologies for AI-driven semiconductor scaling.
North Haven Private Income Fund M&A Deal with North Haven Private Income Fund A LLC
North Haven Private Income Fund LLC (PIF) has entered into a definitive agreement to acquire North Haven Private Income Fund A LLC (PIF A) in a NAV-for-NAV exchange ratio merger. The combined entity is expected to have approximately $6.6 billion in total investments at fair value and will benefit from a reduced management fee of 1.00%. The transaction is expected to close in December 2026, subject to regulatory approvals and customary closing conditions.
Counterparty
North Haven Private Income Fund A LLC
“we are pleased with the Companies’ performance and believe the Merger will create value for investors, including through a reduced management fee. The Merger advances our long-standing strategic vision and better positions PIF to capitalize on the strength of the Morgan Stanley platform to scale further in the marketplace.”
Michael Occi, Chief Executive Officer of the Companies
Senti Biosciences Holdings Divestiture to ST NewCo Limited for $60M
Senti Biosciences completed the divestiture of its entire ownership interest in its operating subsidiaries, Midco and Opco, to ST NewCo Limited. In exchange, Senti shareholders will receive contingent value rights (CVRs) entitling them to up to $60.0 million in milestone payments tied to the FDA approval and commercial success of the CAR-NK cell therapy SENTI-202.
KKR Infrastructure Conglomerate Capital Raise of $243M
KKR Infrastructure Conglomerate LLC sold approximately $242.9 million in unregistered Class I-Series 1, Class S, and Class D shares to investors for cash on October 1, 2026. This sale is part of a continuous private offering that has raised approximately $8,222 million since its inception in June 2023.
Rent the Runway completed a $15 million rights offering, raising approximately $8.9 million from subscribers and $6.1 million from a backstop commitment. An investor group consisting of CHS US Investments LLC, Gateway Runway, LLC, and S3 RR Aggregator, LLC purchased the remaining 1,724,089 unsubscribed shares at $3.55 per share.
Azio AI Holdings announced it has regained compliance with Nasdaq's minimum stockholders' equity requirement of $2.5 million. The company achieved this through a business combination with Azio AI Corporation, warrant exercises, and share issuances under a standby equity purchase agreement. Nasdaq will continue to monitor the company's compliance through its next periodic financial report.
RadNet has entered into a definitive agreement to acquire OnRad, Inc., a provider of teleradiology and in-hospital professional radiology staffing services, for $350 million in cash and 5 million shares of RadNet common stock. The deal includes a potential earn-out of up to $210 million based on 2027 EBITDA targets and will establish a new 'Radiology Professional Services' operating segment for RadNet. The acquisition is expected to close in early 2027 and add approximately $190 million to $200 million in annual revenue.
Value
$350M
Counterparty
OnRad, Inc.
“This is the next step in building an imaging company with comprehensive solutions that brings technology, radiology professional services and imaging operations together to address some of healthcare’s most pressing challenges and needs.”
Dr. Howard Berger, President and CEO of RadNet
“I welcome ONRAD’s executive team, its contracted radiologists and all other ONRAD team members into the RadNet family. This transaction is a significant additional step in leading our industry forward and demonstrating the impact that a transformation to workflow solutions in diagnostic imaging can have in advancing early detection, population health and improved patient outcomes.”
KKR Private Equity Conglomerate Capital Raise of $290M
KKR Private Equity Conglomerate LLC sold approximately $289.5 million in unregistered shares across multiple classes (Class I, U, S, and D) to investors for cash on October 1, 2026. This transaction is part of a continuous private offering that has raised approximately $11.17 billion for the company since its inception in August 2023.
BranchOut Food Inc. priced an underwritten public offering of 2,941,177 shares of common stock at $1.70 per share, raising approximately $5.0 million in gross proceeds. The company intends to use the net proceeds for working capital, general corporate purposes, and capital expenditures.
Ufp Industries Signs $27M M&A Deal with Apache Products, Inc.
UFP Industries has entered into a definitive agreement to acquire the operating assets of Apache Products, Inc. (dba Acme Skid), a Texas-based pallet manufacturer, for approximately $27 million. The acquisition adds approximately $55 million in annual sales and expands UFP Packaging's manufacturing footprint in the Gulf Coast industrial and petrochemical market.
Value
$27M
Counterparty
Apache Products, Inc.
“Apache is the kind of business we look for at UFP: an established market leader with long-standing customer relationships, a disciplined operation and an experienced team that has a proven track record of execution. This acquisition tracks with our other investments this year—broadening our reach into a strategically important geography and creating opportunities to grow with our national customers across the region to create long-term value.”
Will Schwartz, chief executive officer of UFP Industries
“The Gulf Coast is one of the country's most important industrial packaging markets, driven by concentrated manufacturing, energy and petrochemical activity. The team at Apache will expand our ability to support customers as they grow through greater efficiency, scale and access to a larger range of packaging solutions.”
Sound Point Direct Lending BDC Capital Raise of $41.1M
Sound Point Direct Lending BDC issued approximately 1.64 million common shares to investors for aggregate proceeds of approximately $41.1 million. The sale was conducted via a capital drawdown notice under existing subscription agreements and closed on October 22, 2026.
Faraday Future Intelligent Electric Divestiture to FF EAI Robotics Ecosystem Inc. for $200M
Faraday Future completed the sale of its Robotics Business to FF EAI Robotics Ecosystem Inc. (FFR) for an aggregate consideration of $200 million. The transaction establishes FFR as an independent Nasdaq-listed robotics platform while Faraday Future pivots toward Robotaxi and shared mobility operations.
Value
$200M
Counterparty
FF EAI Robotics Ecosystem Inc.
“This transaction represents a transformative milestone for both companies and reinforces our long-term vision to become a leader in the Embodied AI era. Combining RoboShare’s capabilities with a dedicated public-company platform for robotics positions us to accelerate technology development, AI innovation, and commercial growth while expanding the adoption of intelligent robotic solutions across everyday commercial and industrial use cases.”
YT Jia, Founder and Global Chief Executive Officer of Faraday Future
FF EAI Robotics Ecosystem M&A Deal with Faraday Future Intelligent Electric Inc.
FF EAI Robotics Ecosystem Inc. completed its acquisition of the robotics business of Faraday Future Intelligent Electric Inc. (FFAI) on October 23, 2026. The transaction involved the merger of FF EAI Robotics Inc. into a subsidiary of the company and included exclusive technology licensing and intellectual property assignments to establish a standalone Nasdaq-listed robotics platform.
Counterparty
Faraday Future Intelligent Electric Inc.
“The completion of this transaction marks an important milestone in establishing a dedicated public company focused on Embodied AI robotics. We believe this platform provides a strong foundation to accelerate commercialization and expand the adoption of intelligent robotics across real-world applications.”
YT Jia, Chief Executive Officer of FFR
“FFR’s focus is on building a scalable robotics business that brings Physical AI robotic technologies into everyday commercial and industrial applications. We look forward to expanding our products, services and capabilities as we enter into this next stage of growth.”
GigCapital9 Corp. has entered into a non-binding letter of intent for a business combination with a leading clean energy technology company specializing in post-combustion carbon capture. The proposed transaction sets a pre-money enterprise value for the target company of approximately $600 million, plus a potential $100 million earnout. The deal aims to support the commercialization of clean firm power applications required for AI-driven power demand growth.
Peraso Inc. entered into a definitive agreement for a $10 million strategic private placement with Nant Capital, LLC. The offering includes common stock, pre-funded warrants, and accompanying common stock purchase warrants to accelerate the development and commercialization of 60 GHz mmWave technology for drone communications.
Surgery Partners Signs $5.7B M&A Deal with HealthSpan Partners
Surgery Partners, Inc. has entered into a definitive agreement to be acquired by HealthSpan Partners, an affiliate of Bon Secours Mercy Health, in an all-cash transaction with an enterprise value of approximately $5.7 billion. Shareholders will receive $23.50 per share in cash, while Bain Capital will roll over its existing equity to remain a significant partner in the combined outpatient surgical care platform.
Nathans Famous M&A Deal with Smithfield Foods, Inc.
Nathan’s Famous, Inc. completed its merger with Smithfield Foods, Inc., becoming a wholly-owned subsidiary of Smithfield. At the effective time of the merger, Nathan's stockholders became entitled to receive $102.00 in cash for each share of common stock held. In connection with the closing, the company also terminated its existing credit agreement with Citibank, N.A.
Forum Markets Wins $94.4M Contract from Fireworks AI
Forum Edge AI LLC, a joint venture between Forum Markets and Edge Node Inc., signed a definitive agreement with Fireworks AI for a 36-month reservation of 96 enterprise AI servers. The contract has a total value of $94.4 million and involves the deployment of Nvidia B300 GPU capacity at a data center facility in Dallas, Texas.
Boston Omaha Divestiture to CopperPoint Insurance Company for $84.3M
Boston Omaha Corporation completed the sale of its General Indemnity Group (GIG) surety insurance business to CopperPoint Insurance Company for a gross cash purchase price of approximately $84.3 million. As part of the transaction, Boston Omaha retained 2,673,831 shares of Sky Harbour Class A common stock and received a final cash dividend of $326,371. The proceeds will be used for general corporate purposes, new investments, or to fund the company's existing $30 million share repurchase plan.
SHF Holdings (Safe Harbor) signed a non-binding term sheet to combine with Opifex Media, a Beverly Hills-based media holding company focused on the creator economy. The transaction is designed to create a Nasdaq-listed holding company with two distinct businesses and support Safe Harbor's plan to maintain its Nasdaq listing. Following the closing, Opifex would become a wholly owned subsidiary of Safe Harbor and the combined company would operate under a new name.
Aptevo Therapeutics reported clinical data from its Phase 1b RAINIER trial showing that 21% of frontline AML patients treated with mipletamig combination therapy advanced to potentially curative stem cell transplants. This transplant rate compares favorably to historical standard-of-care results (0.7% in the VIALE-A trial) for patients initially deemed unfit for intensive chemotherapy. The company expects to conclude dose optimization by year-end and initiate a Phase 2 trial in the first half of 2027.
Oruka Therapeutics announced positive Week 16 results from its Phase 2b EVERLAST-B clinical trial of ORKA-001 in patients with moderate-to-severe plaque psoriasis. The trial met its primary endpoint with 61% of patients in the high-dose (600 mg) group achieving complete skin clearance (PASI 100) compared to 0% for placebo, supporting the planned initiation of Phase 3 trials in the first half of 2027.
GameSquare Holdings M&A Deal with FanEngine Holdings Ltd.
GameSquare Holdings completed the acquisition of sports, music, and entertainment IP assets from FanEngine Holdings Ltd. in exchange for 5,439,416 shares of common stock. The deal includes rights to franchises like Peaky Blinders and Simon’s Cat, with sellers eligible for up to $50 million in contingent cash earnouts and additional shares based on future revenue milestones.
Counterparty
FanEngine Holdings Ltd.
“Closing this transaction marks the start of a new chapter in GameSquare’s evolution. We have built best-in-class capabilities to measure, reach and engage audiences at scale. With the ability to own the fan relationship and earn from it repeatedly, FanEngine adds an important piece to our ecosystem. We expect that to show up in our results quickly, with FanEngine contributing to our 2026 proforma outlook and supporting 2027 guidance of more than $150 million in revenue and more than $30 million in adjusted EBITDA. Our focus now is integrating the acquisition and executing new commercial opportunities for our owned IP assets.”
Justin Kenna, Chief Executive Officer of GameSquare
Valion Bio has received unsolicited acquisition inquiries from third parties regarding its wholly owned CDMO subsidiary, Velocity Bioworks. The company has retained an investment bank to evaluate strategic options, including a potential sale, while prioritizing the retention of manufacturing rights for its lead drug candidate, Entolimod.